Sectoral Asset Management Inc Amylyx Pharmaceuticals, Inc. Transaction History

Sectoral Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.07 - $18.46 $125,528 - $191,984	10,400 Added 14.12%	84,055 $1.24 Million
Q3 2023 Nov 14, 2023	SELL	$18.08 - $23.45 $5.67 Million - $7.36 Million	-313,655 Reduced 80.98%	73,655 $1.35 Million
Q2 2023 Aug 11, 2023	BUY	$20.98 - $31.42 $3.04 Million - $4.55 Million	144,910 Added 59.78%	387,310 $8.35 Million
Q1 2023 May 12, 2023	BUY	$27.71 - $40.93 $2.34 Million - $3.46 Million	84,450 Added 53.47%	242,400 $7.11 Million
Q4 2022 Feb 10, 2023	SELL	$29.75 - $39.26 $1.41 Million - $1.86 Million	-47,450 Reduced 23.1%	157,950 $5.84 Million
Q3 2022 Nov 10, 2022	BUY	$17.15 - $30.92 $3.52 Million - $6.35 Million	205,400 New	205,400 $5.78 Million

139

46.5M

226K

909K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $290M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.